CPIG
MXCT icon

Chicago Partners Investment Group’s MaxCyte MXCT Stock Holding History

Chicago Partners Investment Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,195
Closed -$9.97K – 1658
2026
Q1 		$9.97K Buy
+11,195
New +$10.5K ﹤0.01% 1472

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Chicago Partners Investment Group's MXCT Position: Q2 2026 in Review

Chicago Partners Investment Group sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 11,195 shares — an estimated $9.97K sold.

Chicago Partners Investment Group first reported a position in MXCT in Q1 2026 and held it in 1 quarter. The position peaked at $9.97K in Q1 2026. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Chicago Partners Investment Group reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 11,195 MaxCyte shares in Q2 2026, an estimated $9.97K.
  • Chicago Partners Investment Group first reported a position in MaxCyte in Q1 2026 and held it in 1 quarter.
  • Chicago Partners Investment Group's MaxCyte position peaked at $9.97K in Q1 2026.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.